As the global youth population increases its use of social media, misinformation continues to be a danger to many. Joseph O’Brien, a manager at Inspira Health’s Behavioral Wellness Center, stated that social media had increased the dangers of self-diagnosis.
Social media apps such as TikTok are already used to spread misinformation, particularly on developmental and mental-health conditions. Various posts include individuals sharing their self-diagnosis of conditions such as autism spectrum disorder despite mental-health professionals on the same TikTok platform highlighting the importance of getting diagnosed by a licensed medical provider.
A recent study by the A.J. Drexel Autism Institute determined that only 27% of popular TikToks related to autism contained accurate information. For their study, the researchers analyzed engagement indicators such as likes and views on TikTok videos linked to the autism hashtag. They fact checked the contents of popular videos, focusing on those that provided information on autism such as what causes the disorder and how to identify it. The researchers then classified the videos as either inaccurate, accurate or overgeneralization, based on the consistency of the data in the videos.
The study found that 41% of these videos were entirely inaccurate while 32% of them were too generalized. In their report, the study found that inaccurate and misleading videos had been viewed nearly 150 million times.
Pediatric psychologist Diane Franz stated that while more attention on autism could bring about better understanding and advocacy for the condition, misleading information on social media was still harmful. She noted that looking for diagnosis to explain differences in behavior and personality minimized the significance of living with a disorder that affected different aspects of an individual’s life and took away from accepting normal variations among adults as well as children.
Franz added that the use of standardized assessments by professionals helped maintain the integrity of the diagnostic system while also ensuring that those who needed help were identified.
It should be noted that autism spectrum disorder diagnosis is done over a period of time because therapists need to collect information while becoming more familiar with their patients.
Other dangers of misinformation of autism on social media include:
- Attaching oneself to misinformation, which may make it hard for therapists to navigate the diagnosis. This is especially true for autism spectrum disorder, cannabis use disorder, mood disorders and borderline personality disorders.
- Watering down of official language used by mental-health providers, which has changed meanings of diagnosis. This is mainly because these terms are used in a way not used by professionals.
Social-media misinformation may also hinder many who would have benefited from the novel ASD treatments being developed by entities such as PaxMedica Inc. (NASDAQ: PXMD) from reaching out to the professionals who can prescribe the suitable medications for the condition.
NOTE TO INVESTORS: The latest news and updates relating to PaxMedica Inc. (NASDAQ: PXMD) are available in the company’s newsroom at https://ibn.fm/PXMD
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is powered by IBN